The Ministry of Food and Drug Safety (MFDS) has published the 2024 National Lot Release Annual Report to transparently disclose the status of national lot release for biological products and to promote the excellence of Korea’s quality control system for biologics.

The main contents of the report include:

- The 2024 national lot release status of vaccines and plasma-derived medicinal products

- Updates on the revision and establishment of relevant regulations

- Public-private partnerships implemented to strengthen quality control capabilities

- Introductions to international collaborations

- Research projects related to biologics quality management